Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
The Effects of the Combined Co-Expression of GroEL/ES and Trigger Factor Chaperones on Orthopoxvirus Phospholipase F13 Production in E. coli. / Merkuleva, Iuliia A.; Nikitin, Vladimir N.; Belaya, Tatyana D. и др.
в: BioTech, Том 13, № 4, 57, 20.12.2024.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - The Effects of the Combined Co-Expression of GroEL/ES and Trigger Factor Chaperones on Orthopoxvirus Phospholipase F13 Production in E. coli
AU - Merkuleva, Iuliia A.
AU - Nikitin, Vladimir N.
AU - Belaya, Tatyana D.
AU - Mustaev, Egor A.
AU - Shcherbakov, Dmitriy N.
N1 - Финансирование: Ministry of Education and Science of the Russian Federation 075-15-2021-1355
PY - 2024/12/20
Y1 - 2024/12/20
N2 - Heterologous protein expression often faces significant challenges, particularly when the target protein has posttranslational modifications, is toxic, or is prone to misfolding. These issues can result in low expression levels, aggregation, or even cell death. Such problems are exemplified by the expression of phospholipase p37, a critical target for chemotherapeutic drugs against pathogenic human orthopoxviruses, including monkeypox and smallpox viruses. The complex structure and broad enzymatic activity of phospholipase p37 render it toxic to host cells, necessitating specialized strategies for heterologous expression. In our study, we addressed these challenges using the vaccinia virus F13 protein as a model. We demonstrated that p37 can be effectively synthesized in E. coli as a GST fusion protein by co-expressing it with the GroEL/ES chaperone system and Trigger Factor chaperone.
AB - Heterologous protein expression often faces significant challenges, particularly when the target protein has posttranslational modifications, is toxic, or is prone to misfolding. These issues can result in low expression levels, aggregation, or even cell death. Such problems are exemplified by the expression of phospholipase p37, a critical target for chemotherapeutic drugs against pathogenic human orthopoxviruses, including monkeypox and smallpox viruses. The complex structure and broad enzymatic activity of phospholipase p37 render it toxic to host cells, necessitating specialized strategies for heterologous expression. In our study, we addressed these challenges using the vaccinia virus F13 protein as a model. We demonstrated that p37 can be effectively synthesized in E. coli as a GST fusion protein by co-expressing it with the GroEL/ES chaperone system and Trigger Factor chaperone.
KW - GroEL/ES
KW - NIOCH-14
KW - ST-246
KW - chaperone
KW - monkeypox virus
KW - orthopoxviruses
KW - p37
KW - phospholipase F13
KW - trigger factor
KW - chaperone
KW - GroEL/ES
KW - monkeypox virus
KW - NIOCH-14
KW - orthopoxviruses
KW - p37
KW - phospholipase F13
KW - ST-246
KW - trigger factor
UR - https://www.mendeley.com/catalogue/e6cbbee0-d1f8-3e74-a39a-f3a9ea8bbdd3/
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85213024144&origin=inward&txGid=f0f246fcf6725ace46bc1f1345e80bef
U2 - 10.3390/biotech13040057
DO - 10.3390/biotech13040057
M3 - Article
C2 - 39727494
VL - 13
JO - BioTech
JF - BioTech
SN - 2673-6284
IS - 4
M1 - 57
ER -
ID: 61415709